Your fact-checks will appear here
The use of ivermectin to treat or prevent COVID-19, its safety and efficacy, and the risks associated with its misuse.
Ivermectin is FDA‑approved for specific antiparasitic and dermatologic uses in humans — primarily oral formulations for certain parasitic worm infections and topical formulations for skin conditions —...
The FDA has repeatedly warned Americans not to use veterinary formulations of ivermectin to prevent or treat COVID-19, stressing that animal products are not evaluated for human safety and that self‑m...
The U.S. Food and Drug Administration (FDA) repeatedly warned that ivermectin is not authorized or approved to prevent or treat COVID‑19 in humans and alerted the public that people taking veterinary ...
Published case series and poison‑center reviews show a clear pattern: toxicity linked to veterinary ivermectin is driven by higher ingested doses and unusual routes/formulations and presents with more...
The FDA‑approved oral ivermectin (Stromectol) for human parasitic infections is dosed by body weight, most commonly as a single dose in the range of 150 to 200 micrograms per kilogram (mcg/kg) dependi...
There have been no sweeping new FDA approvals of ivermectin for additional human parasitic diseases in the past two years; the agency’s approved human uses remain focused on specific nematode infectio...
Using veterinary ivermectin preparations or veterinary-level doses in humans carries clear, well-documented risks: veterinary formulations are concentrated for much larger animals and can cause toxic ...
Federal health agencies warn strongly against using veterinary ivermectin in humans because it is not approved for COVID-19, can be highly concentrated and toxic, and because real‑world signals—rising...